Solid Tumors clinical trials
Showing 1,001–1,050 of 1,133 active trials. Describe your situation to see which ones look like a fit.
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- ASk Questions in GYnecologic Oncology (ASQ-GYO)
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
- Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
- Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
- Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
- Better Options for Chronic Cancer Pain
- IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
- Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial
- Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors
- Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
- A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
- B7-H3.CD28Z.CART in Solid Tumors
- Real-world Trial of Individualized Precision Oncology
- Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
- Feasibility Study for Repurposing RET Inhibitors
- A Study of CS231295 in Patients With Advanced Solid Tumors
- NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
- A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
- EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
- Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
- CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer
- Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
- Wet Heparinized Suction for Abdominal Cancer
- Algorithm-enabled Goals of Care Communication
- First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors
- First-in-Human Trial of VBC108 in Participants With Advanced Malignant Solid Tumors
- UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
- Collection of Biological Specimens and Associated Health Information
- Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients
- Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
- Adoption of Audio Recording in the Outpatient Supportive Care Center
- Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
- Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)
- THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia
- A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
- A Pilot Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
- A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.